Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical Technology Enterprise Consortium, 61071 [2019-24477]

Download as PDF Federal Register / Vol. 84, No. 218 / Tuesday, November 12, 2019 / Notices plaintiffs to actual damages under specified circumstances. Pursuant to Section 6(b) of the Act, the identities of the parties to the venture are: Bayer Health Care, LLC, Animal Health Division, Shawnee, KS; Central Garden & Pet Company, Schaumburg, IL; Elanco U.S. Inc., Greenfield, IN; The Hartz Mountain Corporation, Secaucus, NJ; and Pet IQ, Omaha, NE. The general area of PCPTF’s planned activity is to develop proposed Standard Operating Procedures (‘‘SOPs’’) to amend or replace the current United States Environmental Protection Agency (‘‘EPA’’) SOP developed for pet care products in 2012 by (i) reviewing and analyzing existing pet care product exposure assessment methods from EPA, Health Canada Pest Management Regulatory Agency (‘‘PMRA’’) and European Medicines Agency (‘‘EMA’’); (ii) developing a scoping document that outlines options available for an exposure assessment method, including advantages and disadvantages for each option, and, where necessary, any related data refinement costs for each option; and (iii) meeting with the EPA Office of Pesticide Products to present options for the revised SOPS and to solicit feedback. Suzanne Morris, Chief, Premerger and Division Statistics Unit Antitrust Division. [FR Doc. 2019–24485 Filed 11–8–19; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Medical Technology Enterprise Consortium Notice is hereby given that, on October 17, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Attorney General and the Federal Trade Commission (‘‘MTEC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Alentic Microscience Inc., Halifax, Nova Scocia, Canada; Allied Technologies and Consulting, LLC, Frederick, MD; Amicrobe, Inc., Carlsbad, CA; BioTether Sciences, Inc., VerDate Sep<11>2014 17:47 Nov 08, 2019 Jkt 250001 San Rafael, CA; Boa Biomedical, Inc., Cambridge, MA; Booz Allen Hamilton, Inc., McLean, VA; bR3 UNIQ, Inc. dba QUADYSTER, Bettendorf, IA; Calimex USA Corporation, San Francisco, CA; Cognosante, Falls Church, VA; Concurrent Technologies Corporation, Johnstown, PA; CUBRC, Inc., Buffalo, NY; Dawson Technical Inc., Irvine, CA; Distributed Bio, South San Francisco, CA; Expression Networks LLC, Washington, DC; GoDx, Inc., Madison, WI; InnoSense LLC, Torrance, CA; J. David Gladstone Institutes, San Francisco, CA; Kane Biotech Inc., Winnipeg, Manitoba, MB; Kindred Biosciences, Inc., Burlingame, CA; Latham BioPharm Group Inc., Cambridge, MA; MO–SCI Corporation, Rolla, MO; MRI Global, Kansas City, MO; Nanohmics Inc., Austin, TX; NUES LLC, Silver Spring, MD; Odic Incorporated, Littleton, MA; Ontario Corp. dba Flosonics Medical, Sudbury, Ontario, Canada; PEER Technologies PLLC, Fairfax, VA; PolarityTE MD, Inc., Salt Lake City, UT; Praeses, LLC, Shreveport, LA; Presence Product Group, LLC, San Francisco, CA; Regents of the University of Colorado Denver, Aurora, CO; Rochal Industries LLC, San Antonio, TX; SmartPoints Technology, Inc., Stow, MA; Tasso, Inc., Seattle, WA; TBT Pharma, LLC, Baltimore, MD; The Children’s Hospital of Philadelphia Research Institute, Philadelphia, PA; The Pennsylvania State University, University Park, PA; and Wello, Inc., Addison, TX, have been added as parties to this venture. Also, Centaur Biopharmaceutical Services, Inc., Burlingame, CA, has withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MTEC intends to file additional written notifications disclosing all changes in membership. On May 9, 2014, MTEC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on June 9, 2014 (79 FR 32999). The last notification was filed with the Department on July 11, 2019. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on August 1, 2019 (84 FR 37680). Suzanne Morris, Chief, Premerger and Division Statistics Unit Antitrust Division. [FR Doc. 2019–24477 Filed 11–8–19; 8:45 am] BILLING CODE 4410–11–P PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 61071 DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—American Society of Mechanical Engineers Notice is hereby given that, on September 6, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), the American Society of American Society of Mechanical Engineers (‘‘ASME’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing additions or changes to its standards development activities. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, since April 22, 2019, ASME has published eight new standards, added one consensus committee charter, revised one consensus committee charter, initiated nine new standards activities, and withdrawn two proposed standards from consideration within the general nature and scope of ASME’s standards development activities, as specified in its original notification. More detail regarding these changes can be found at www.asme.org. On September 15, 2004, ASME filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on October 13, 2004 (69 FR 60895). The last notification with the Attorney General was filed on April 22, 2019. A notice was filed in the Federal Register on May 13, 2019 (84 FR 20908). Suzanne Morris, Chief, Premerger and Division Statistics Unit Antitrust Division. [FR Doc. 2019–24484 Filed 11–8–19; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Naval Surface Technology & Innovation Consortium Notice is hereby given that, on October 8, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, E:\FR\FM\12NON1.SGM 12NON1

Agencies

[Federal Register Volume 84, Number 218 (Tuesday, November 12, 2019)]
[Notices]
[Page 61071]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24477]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical Technology Enterprise Consortium

    Notice is hereby given that, on October 17, 2019, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Attorney General and the 
Federal Trade Commission (``MTEC'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership. The notifications were 
filed for the purpose of extending the Act's provisions limiting the 
recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Specifically, Alentic Microscience Inc., Halifax, Nova 
Scocia, Canada; Allied Technologies and Consulting, LLC, Frederick, MD; 
Amicrobe, Inc., Carlsbad, CA; BioTether Sciences, Inc., San Rafael, CA; 
Boa Biomedical, Inc., Cambridge, MA; Booz Allen Hamilton, Inc., McLean, 
VA; bR3 UNIQ, Inc. dba QUADYSTER, Bettendorf, IA; Calimex USA 
Corporation, San Francisco, CA; Cognosante, Falls Church, VA; 
Concurrent Technologies Corporation, Johnstown, PA; CUBRC, Inc., 
Buffalo, NY; Dawson Technical Inc., Irvine, CA; Distributed Bio, South 
San Francisco, CA; Expression Networks LLC, Washington, DC; GoDx, Inc., 
Madison, WI; InnoSense LLC, Torrance, CA; J. David Gladstone 
Institutes, San Francisco, CA; Kane Biotech Inc., Winnipeg, Manitoba, 
MB; Kindred Biosciences, Inc., Burlingame, CA; Latham BioPharm Group 
Inc., Cambridge, MA; MO-SCI Corporation, Rolla, MO; MRI Global, Kansas 
City, MO; Nanohmics Inc., Austin, TX; NUES LLC, Silver Spring, MD; Odic 
Incorporated, Littleton, MA; Ontario Corp. dba Flosonics Medical, 
Sudbury, Ontario, Canada; PEER Technologies PLLC, Fairfax, VA; 
PolarityTE MD, Inc., Salt Lake City, UT; Praeses, LLC, Shreveport, LA; 
Presence Product Group, LLC, San Francisco, CA; Regents of the 
University of Colorado Denver, Aurora, CO; Rochal Industries LLC, San 
Antonio, TX; SmartPoints Technology, Inc., Stow, MA; Tasso, Inc., 
Seattle, WA; TBT Pharma, LLC, Baltimore, MD; The Children's Hospital of 
Philadelphia Research Institute, Philadelphia, PA; The Pennsylvania 
State University, University Park, PA; and Wello, Inc., Addison, TX, 
have been added as parties to this venture.
    Also, Centaur Biopharmaceutical Services, Inc., Burlingame, CA, has 
withdrawn as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MTEC intends to file additional 
written notifications disclosing all changes in membership.
    On May 9, 2014, MTEC filed its original notification pursuant to 
Section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to Section 6(b) of the Act on June 9, 
2014 (79 FR 32999).
    The last notification was filed with the Department on July 11, 
2019. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on August 1, 2019 (84 FR 37680).

Suzanne Morris,
Chief, Premerger and Division Statistics Unit Antitrust Division.
[FR Doc. 2019-24477 Filed 11-8-19; 8:45 am]
 BILLING CODE 4410-11-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.